IL1B and melanoma: Polymorphisms in the NLRP3 gene have been linked to the development of malignant melanoma [179], with an activation amplitude correlating with the stage of the disease; constitutive inflammasome activation is often found in late stages of melanoma, surrounded by elevated IL-1β level.